BioPharma Dive ٢٣ مارس ٢٠٢٦ Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
BioPharma Dive ٦ مارس ٢٠٢٦ Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
BioPharma Dive ٤ فبراير ٢٠٢٦ Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
BioPharma Dive ١٢ يناير ٢٠٢٦ JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year